Skip Navigation

eCAM 2004 1(1):93-98; doi:10.1093/ecam/neh009
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Clavo, B.
Right arrow Articles by Robaina, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clavo, B.
Right arrow Articles by Robaina, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© Oxford University Press, 2004.

Original Article

Ozone Therapy for Tumor Oxygenation: a Pilot Study

Bernardino Clavo1,5,, Juan L. Pérez2,5, Laura López1,5, Gerardo Suárez1,5, Marta Lloret1,5, Victor Rodríguez3, David Macías2,5, Maite Santana1, María A. Hernández1,5, Roberto Martín-Oliva2 and Francisco Robaina4,5

1Radiation Oncology and Research Unit, Las Palmas (Canary Islands), Spain, 2Medical Physics, Las Palmas (Canary Islands), Spain, 3La Paterna Medical Center, Las Palmas (Canary Islands), Spain, 4Chronic Pain Unit, Dr Negrín Hospital, Las Palmas (Canary Islands), Spain, and 5Canary Islands Institute for Cancer Research (ICIC), Las Palmas (Canary Islands), Spain

Tumor hypoxia is an adverse factor for chemotherapy and radiotherapy. Ozone therapy is a non-conventional form of medicine that has been used successfully in the treatment of ischemic disorders. This prospective study was designed to assess the effect of ozone therapy on tumor oxygenation. Eighteen subjects were recruited for the study. Systemic ozone therapy was administered by autohemotransfusion on three alternate days over one week. Tumor oxygenation levels were measured using polarographic needle probes before and after the first and the third ozone therapy session. Overall, no statistically significant change was observed in the tumor oxygenation in the 18 patients. However, a significant decrease was observed in hypoxic values ≤10 and ≤5 mmHg of pO2. When individually assessed, a significant and inverse non-linear correlation was observed between increase in oxygenation and the initial tumor pO2 values at each measuring time-point, thus indicating that the more poorly-oxygenated tumors benefited most (rho = –0.725; P = 0.001). Additionally, the effect of ozone therapy was found to be lower in patients with higher hemoglobin concentrations (rho = –0.531; P < 0.034). Despite being administered over a very short period, ozone therapy improved oxygenation in the most hypoxic tumors. Ozone therapy as adjuvant in chemo-radiotherapy warrants further research.

Keywords: cancer – hypoxia – pO2 measurement – polarographic probe

For reprints and all correspondence: Bernardino Clavo, Department of Radiation Oncology and Research Unit, Dr Negrín Hospital, C/ Barranco la Ballena s/n, 35020 Las Palmas (Canary Islands), Spain. Fax: (+34) 928 449127; Tel: (+34) 928 450284. E-mail: bernardinoclavo{at}terra.es


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Evid Based Complement Alternat MedHome page
B. Clavo, L. Catala, J. L. Perez, V. Rodriguez, and F. Robaina
Ozone Therapy on Cerebral Blood Flow: A Preliminary Report
Evid. Based Complement. Altern. Med., December 1, 2004; 1(3): 315 - 319.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.